Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

apc pharmaceuticals & chemicals (europe) ltd - ramipril - oral tablet - 2.5mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - ramipril - oral capsule - 2.5mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - ramipril - oral capsule - 5mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - ramipril - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - ramipril - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - ramipril - oral tablet - 1.25mg

Bretland - enska - myHealthbox

mip pharma gmbh - ceftazidime - powder for solution for injection/infusion - 1g - antibacterials for systemic use. third-generation cephalosporins - it is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia - broncho-pulmonary infections in cystic fibrosis - bacterial meningitis - chronic suppurative otitis media - malignant otitis externa - complicated urinary tract infections - complicated skin and soft tissue infections - complicated intra-abdominal infections - bone and joint infections - peritonitis associated with dialysis in patients on capd

Írland - enska - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ramipril - tablet - 2.5 milligram(s) - ace inhibitors, plain; ramipril

Írland - enska - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ramipril - tablet - 10 milligram(s) - ace inhibitors, plain; ramipril

Írland - enska - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ramipril - tablet - 1.25 milligram(s) - ace inhibitors, plain; ramipril